drugset / Trial / NCT00728689
Phase I Trial of an Investigational Small Pox Medication
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study was to evaluate the pharmacokinetic parameters and safety of a single dose of ST-246 400mg Form I versus ST-246 400mg Form V capsules in fed normal healthy volunteers.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tecovirimat | Small molecule | 400 mg | Oral |